Stay informed with the newest research on longevity, NAD+ biology, and healthy aging from world-class institutions.
AIDEVI announces a major milestone as its science-driven longevity supplements reach over 200,000 satisfied customers worldwide. The brand simultaneously expands its distribution network to 15 additional countries across Europe, Asia, and Latin America, making high-purity NAD+ and EGT formulas more accessible to health-conscious consumers globally.
AIDEVI unveils its latest innovation: a sustained-release NAD+ precursor formula featuring advanced delivery technology that extends absorption window by 3x compared to standard formulations. The new product maintains stable NAD+ levels throughout the day, addressing the common issue of rapid metabolism and energy crashes associated with conventional supplements.
The global longevity supplement market experiences unprecedented growth in 2024, with NAD+ precursors leading the category at 340% year-over-year increase. Industry analysts attribute this surge to growing consumer awareness of cellular aging science, increased clinical research validation, and demand for science-backed wellness solutions among health-conscious demographics aged 35-65.
A groundbreaking 2024 study from Harvard Medical School demonstrates that NMN supplementation can restore NAD+ levels by 40% in aged mice, significantly improving insulin sensitivity and mitochondrial function. The research suggests potential applications for human metabolic health.
MIT Longevity Lab has discovered a novel mechanism by which NAD+ precursors activate SIRT1 and SIRT6 simultaneously, showing 2.5x greater sirtuin activation compared to previous formulations. This breakthrough could accelerate the development of next-generation longevity supplements.
A randomized controlled trial involving 200 healthy adults found that 6-month NMN supplementation improved vascular endothelial function and reduced arterial stiffness by 15%. Participants also reported enhanced energy levels and cognitive performance.
New research from Washington University demonstrates that Ergothioneine (EGT) uniquely crosses the blood-brain barrier and accumulates in neural tissues, providing powerful antioxidant protection against cognitive decline and neurodegenerative diseases.
Stanford University researchers have shown that NAD+ precursors stimulate PGC-1α, the master regulator of mitochondrial biogenesis, helping restore youthful energy production capacity in aging cells. The study provides mechanistic evidence for NAD+ supplementation benefits.
Oxford University's longitudinal study reveals that maintaining adequate NAD+ levels supports telomerase activity through SIRT6 activation, helping preserve telomere length and cellular replicative capacity. This finding connects NAD+ metabolism directly to cellular aging markers.
Cambridge University research demonstrates that NAD+ optimization upregulates both autophagy and mitophagy processes, helping cells remove damaged proteins and dysfunctional mitochondria. These findings support the role of NAD+ in cellular quality control.
Mayo Clinic's comprehensive study reveals that combining NAD+ precursors with resveratrol produces synergistic effects on sirtuin activation and metabolic health, outperforming either compound alone. The research supports multi-target approaches to healthy aging.
Researchers at UCSF have found that higher levels of Akkermansia muciniphila in the gut microbiome are strongly associated with improved metabolic markers, reduced inflammation, and healthier aging. The study suggests that targeted probiotic supplementation may support gut barrier integrity and metabolic wellness in older adults.
A double-blind, placebo-controlled trial at Seoul National University demonstrated that daily oral collagen peptide supplementation significantly improved skin elasticity by 28% and reduced wrinkle depth by 20% over 12 weeks. The study also found increased dermal collagen density, supporting the role of targeted nutritional intervention in skin aging.
A longitudinal study from Johns Hopkins University reveals that age-related NAD+ decline directly impairs the expression of circadian clock genes, leading to fragmented sleep and reduced deep sleep duration. Restoring NAD+ levels through supplementation showed measurable improvements in sleep architecture and next-day cognitive performance in participants over 50.
Subscribe to receive weekly updates on longevity science, new clinical trials, and breakthrough discoveries in healthy aging.
Science-driven formulas based on the latest research in longevity and cellular health.
View Products